Device for receiving samples

EP4466103A1Inactive Publication Date: 2024-11-27PROCOMCURE BIOTECH GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
EP2022703921
Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-01-21
Filing Date
2022-02-03
Publication Date
2024-11-27
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current PCR methods for detecting pathogenic viruses, such as SARS-CoV-2, are time-consuming, require specialist personnel, and involve sample transportation and purification, making them unsuitable for rapid on-site diagnosis and containment of viral spread.

Method used

A device for receiving biological samples that includes a container with a closure system and a sampling device, allowing for on-site PCR testing without the need for sample purification, using a liquid preparation composition containing guanidinium thiocyanate, surfactants, and RNAase inhibitors, enabling direct PCR analysis at the point of care.

Benefits of technology

Enables rapid, reliable, and cost-effective on-site detection of pathogenic viruses, reducing contamination risks and the need for specialized facilities, facilitating timely targeted therapies and measures to combat viral spread.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 1.1
    Figure 1.1
Patent Text Reader

Abstract

Device (1) for receiving biological samples for carrying out a PCR analysis method for determination of pathogenic microorganisms, in particular pathogenic viruses, especially viruses that cause respiratory diseases, having - a receiving container (2) with a first opening (4), and a closure device (6) which is adapted to the opening (4) of the receiving container (2) such that the opening (4) of the receiving container (2) is able to be closed with the closure device (6), wherein the closure device (6) has a through-opening (20), characterized in that the receiving container contains a liquid preparation composition for point-of-care implementation of a PCR test.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Device for taking samples

[0002] The invention relates to a device for collecting samples for conducting a PCR analysis method for the determination of pathogenic microorganisms, in particular pathogenic viruses, especially viruses that cause respiratory diseases. The devices according to the invention are suitable for conducting on-site PCR methods (point of care; PoC-PCR). Furthermore, the invention relates to the use of the device for a PoC PCR test method and to methods for conducting an on-site PCR method (PoC-PCR).

[0003] Pathogenic viruses that cause respiratory diseases often spread rapidly and can lead to complex infections and even pandemics. Recently, the spread of coronaviruses, particularly SARS-CoV-2, has led to a pandemic with significant health and economic damage. A key component of pandemic control is reliable and rapid diagnostics for the presence of pathogenic viruses, enabling targeted therapies and measures to be initiated and thus contain the spread.

[0004] PCR methods, which are typically performed in specialized laboratories, are considered the reliable gold standard for the detection of pathogenic viruses, especially SARS-CoV-2 viruses. However, these PCR tests are time-consuming, can only be performed by specialized personnel, and require purification and transport of the collected patient samples from the sampling site to the laboratory.

[0005] There is therefore a great need for reliable and rapid tests to identify pathogenic viruses.

[0006] It was surprisingly discovered that, with the help of suitable sample collection devices, PCR tests (PoC; point of care) can be conducted on-site. A particular advantage is that it eliminates the need for complex transport of the collected patient samples and eliminates the need for time-consuming sample purification. PCR tests can thus be performed close to the patient and directly on-site, for example, in testing centers, pharmacies, or doctor's offices.

[0007] The sampling devices must not only be practical and easy to use on-site, but must also be equipped and designed in such a way that PCR tests can be carried out directly on-site.

[0008] This object is achieved by the subject matter according to the independent claims of the present invention. The dependent claims reflect advantageous and preferred embodiments of the present invention.

[0009] One subject of the invention is a device for receiving biological samples for carrying out a PCR analysis method for determining pathogenic microorganisms, in particular pathogenic viruses, especially viruses that cause respiratory diseases, comprising a receiving container with a first opening, a closure device that is adapted to the opening of the receiving container so that the opening of the receiving container can be closed with the closure device, wherein the closure device has a through-opening and wherein the receiving container contains a liquid processing composition for carrying out a PCR test on site (point of care; PoC).

[0010] In an advantageous embodiment, the device further comprises a sampling device having at least one first sampling element at a first free end, with which the sample can be taken, and wherein the sampling device can be inserted into the receiving container. This embodiment has the advantage that the device and sampling device are present together in one system, thus making it practical to use and also reducing the risk of contamination.

[0011] Preferably, the sampling device is connected to the closure device at a second end opposite the first free end, so that the sampling device can be inserted into the receiving container by means of the closure device. In a further preferred embodiment, the through-opening of the closure device is closed by means of a closure element, wherein the closure element is detachably attached to the closure element.

[0012] In a further embodiment, the sampling device has at least one hollow rod-shaped element, at the free end of which the sampling element is arranged, wherein the hollow rod-shaped element forms a channel in the interior.

[0013] The rod-shaped element can be connected to the closure device in such a way that the channel of the rod-shaped element opens into the through-opening or is arranged in it.

[0014] In a preferred embodiment, the through-opening of the closure element is closed on the side opposite the sampling element by means of a closure element which is separably attached to the closure element.

[0015] For practical handling reasons, it is advantageous for the end element to be detachable from the closure element by bending it. However, other alternatives familiar to those skilled in the art are also possible and applicable. For example, the end element can also be detachable by twisting it off.

[0016] In one embodiment, the hollow rod-shaped element has at least one opening at the free end. It is particularly preferred that the end of the channel arranged in the rod-shaped element forms the opening at the free end. It is further preferred that the opening arranged at the free end be arranged in the wall of the rod-shaped element.

[0017] Advantageously, the device, in particular the receiving container, has an identification code. This enables the quick and secure association of patient information with the sample to be analyzed. This can prevent confusion during the execution, evaluation, and identification, particularly when performing PCR tests on multiple samples simultaneously.

[0018] The device of the present invention is particularly suitable for on-site testing for coronaviruses. The viruses are preferably coronaviruses, especially SARS-CoV-2 viruses.

[0019] In principle, the devices according to the invention can be used specifically for viruses that cause respiratory diseases. Preferably, one or more viruses are selected from the group consisting of SARS-CoV-2 virus, influenza virus, and adenovirus.

[0020] PCR tests in the field of virus analysis and detection are known to those skilled in the art. Within the scope of the present invention, it is advantageous if the PCR test is a quantitative PCR method (qPCR) or a quantitative real-time PCR (RT-qPCR).

[0021] The biological samples, especially for the investigation of viruses that cause respiratory diseases, are preferably saliva and / or nasopharyngeal secretions.

[0022] An essential component of the present invention is that the receptacle contains a liquid processing composition for conducting a PCR test on-site (point of care; PoC). The processing composition ensures that the biological samples can be tested directly on-site using a PCR method without the need for further sample purification. The liquid processing composition preferably comprises guanidinium thiocyanate. The processing composition is preferably an aqueous composition. It has been found advantageous to keep the concentration of the guanidinium thiocyanate below 1 / 1M. This improves the direct use of the biological sample together with the processing composition in a PCR test.

[0023] The liquid treatment composition preferably also contains one or more surfactants. The liquid treatment composition advantageously also contains one or more RNAase inhibitors, preferably two different RNAse inhibitors.

[0024] It has been shown to be advantageous for the liquid preparation composition to contain a buffer. This is particularly due to the fact that biological samples, especially saliva and nasophyngeal secretions, can have different pH values ​​depending on the patient.

[0025] The liquid preparation composition preferably contains biotin.

[0026] A further subject matter is the use of the device according to the invention for a PoC PCR test method.

[0027] A further subject matter is a method for carrying out an on-site PCR method (PoC-PCR) comprising the following steps: a) providing a device according to the invention, b) contacting a biological sample, preferably saliva and / or nasopharyngeal secretion, with the liquid preparation composition for carrying out a PCR test on-site (point of care; PoC), c) using the liquid preparation composition comprising the biological sample in a PoC-PCR method.

[0028] In a preferred embodiment, the liquid treatment composition is incubated together with the biological sample, preferably at 15 to 30 °C and in particular for a period of 1 to 30 minutes, especially 2 to 15 minutes and in particular 3 to 10 minutes.

[0029] In a further embodiment of the method, the sample-containing preparation composition can be mixed with a PCR reaction mixture.

[0030] The PCR reaction mixture preferably comprises polymerase and primers and probes for the detection of pathogenic microorganisms, in particular pathogenic viruses, specifically viruses that cause respiratory diseases. In a specific embodiment, the method according to the invention comprises the following steps: a) providing a device according to the invention, b) contacting a biological sample, preferably saliva and / or nasopharyngeal secretion, with the liquid processing composition for on-site (point of care; PoC) performance of a PCR test for the determination of coronaviruses, in particular SARS CoV-2 viruses, c) optionally incubating the liquid processing composition together with the biological sample, d) mixing the liquid processing composition comprising the biological sample with a PCR reaction mixture comprising polymerase and primers and probes for the detection of coronaviruses, in particular SARS CoV-2 viruses.

[0031] Preferably, the PoC-PCR method is a multiplex PCR method.

[0032] The PCR reaction mixture comprises 2 or more probes for the detection of SARS-CoV-2 viruses, 2 or more primers and polymerase, in particular Taq polymerase, reverse transcriptase and optionally a buffer.

[0033] A further subject matter is a kit comprising a) a device according to the invention, b) optionally a sampling device and c) optionally one or more separate containers with one or more PCR reaction mixtures.

[0034] The embodiment shown in Figures 1 to 5 is explained in more detail below. The liquid treatment composition is not shown in the figures. This is located in the receiving container.

[0035] The invention advantageously provides that the sampling device is connected to the closure device at a second end opposite the first free end, so that the sampling device can be inserted into the receiving container by means of the closure device. This embodiment of the present invention has the advantage of simplifying sample collection. The sampling device does not first have to be relocated to open the closure device. Furthermore, the closure device does not have to be relocated to allow the sampling device to be inserted into the receiving container.

[0036] The sampling device may comprise at least one hollow rod-shaped element, at the free end of which the sampling element is arranged, wherein the hollow rod-shaped element forms a channel in the interior.

[0037] The dispensing element can be made of a material that can be absorbent or adhesive to liquids. This means that the dispensing element can absorb the liquid, or the liquid can adhere to the dispensing element.

[0038] An absorbent material could be, for example, cotton wool. Alternatively, it could be any other material that can absorb moisture.

[0039] The receptacle can be waterproof and airtight.

[0040] The closure device may have a through opening.

[0041] The rod-shaped element can be connected to the closure device in such a way that the channel of the rod-shaped element opens into the through-opening or is arranged in it.

[0042] The passage opening of the closure element can be closed on the side opposite the sampling element by means of a closure element which is detachably attached to the closure element.

[0043] Once the closure element is removed, the through-hole forms an opening to the outside. With the closure element removed, the treatment composition liquid in the receiving container can escape to the outside via the channel of the rod-shaped element and the through-hole due to capillary action and / or pressure and / or negative pressure.

[0044] The end element can be separated from the closure element by bending it. Alternatively, the end element can also be separated from the closure element by unscrewing it.

[0045] The hollow rod-shaped element may have at least one opening at the free end.

[0046] The end of the channel arranged in the rod-shaped element can form the opening at the free end.

[0047] The opening arranged at the free end can be arranged in the wall of the rod-shaped element.

[0048] Furthermore, a method for taking samples, in particular saliva samples for the detection of SAR.S-CoV-2 virus in saliva can be provided, the method comprising the following steps

[0049] - Providing a receiving container with a first opening,

[0050] - Taking a sample with at least one sampling element arranged at a free end of a sampling device, wherein

[0051] - the sampling device is connected to a closure device at a second end opposite the first free end and is introduced into the receiving container by means of the closure device and the receiving container is closed with the closure device.

[0052] The liquid can be introduced into the receiving container, and the sampling element of the sampling device can be immersed in the treatment composition liquid upon insertion into the receiving container. The liquid can be guided through a channel arranged in a rod-shaped element of the sampling device to a through-opening of the closure device.

[0053] The liquid can be guided to the passage opening due to capillary action and / or pressure and / or negative pressure.

[0054] The passage opening can be closed with a closing element and the closing element can be separated from the closing device.

[0055] The liquid which is guided through the channel arranged in the rod-shaped element of the sampling device to the through-opening of the closure device can be dispensed or poured out of the through-opening after the closure element has been separated from the closure device.

[0056] Commercially available devices, such as thermal cyclers, are available for performing the POC PCR procedure. PCR is a widely used method in molecular biology that uses thermal cycling to produce millions to billions of copies of a specific RNA / DNA sample in a very short time.

[0057] Point-of-care (PoC) analyzers offer many advantages. They are mobile, lightweight, flexible, and, above all, fast. Results can be available in less than 15 minutes. The name clearly indicates the most appropriate location for a PoC system: in close proximity to the patient and their treatment (point of care).

[0058] The mobile devices are rapid test systems for the qualitative detection of infectious diseases. The testing is based on nucleic acid amplification technology (NAT). Therefore, some product descriptions do not explicitly state "PoC PCR device." However, the PCR method falls under nucleic acid amplification technology. Most devices can detect not only SARS-CoV-2 but also other diseases. The ID Now™ device from Abbott, for example, can also detect influenza, RSV, or Streptococcus A infection.

[0059] Abbott's ID NOW™ is a molecular diagnostic test system for the qualitative detection of infectious diseases such as COVID-19 and influenza. Using isothermal nucleic acid amplification (NAT) technology, the test device delivers reliable, laboratory-quality results.

[0060] Typical real-time q PCR systems for POC analysis can analyze multiple samples simultaneously, for example 16, 24, or 32. In addition, the devices preferably have channels for detection, for example one or more channels for FAM / SYBR Green, VIC / JOE / HEX / TET, ABY / NED / TAMRA / Cy3, JUN, ROX / Texas RED, Cy5.

[0061] The reaction volume used is typically 5 pL - 50 pL.

[0062] For example, the temperature ramp rate at which the preferred thermal cyclers can be operated is 5°C / s for heating and 5°C / s for cooling.

[0063] The PoC PCR analyzers typically support DNA probes, preferably one or more selected from DNA binding dyes (e.g. SybrGreen), hydrolysis probes (e.g. TaqMan probe) and hybridization probes (e.g. FRET probes).

[0064] In a preferred embodiment of the present invention, the qPCR test device has a housing. A test module is arranged in the housing for receiving at least one test sample, preferably 4 to 64, in particular 16 to 24 test samples. A control module is connected to the test module, wherein the control module is designed to control the test module so that qPCR tests are carried out by the test module to determine a test result. The qPCR test device preferably has a transmission module which is connected to the control module. The transmission module is designed to transmit the test result and / or status information of the qPCR test device to at least one recipient. Thus, according to a preferred embodiment of the present invention, the qPCR test device is designed to transmit the test result to at least one recipient directly and without manual transmission of the test result.Alternatively or additionally, status information from the qPCR test device can be transmitted to the at least one recipient via the transmission module. This allows the recipient to determine the function of the qPCR test device, making tampering with the qPCR test device more difficult, for example. For example, the point-of-care qPCR test device can be set up in a pharmacy, at a general practitioner's office, an outpatient clinic, a mobile station, or the like. The sample is then taken at the same location. The sample is tested using the qPCR test device. The test result is then automatically transmitted to at least one recipient. The recipient could be, for example, a public / official body, particularly for the registration of notifiable diseases, or another registration body / database for registering the test result.In particular, the transmission is anonymized. Alternatively, the recipient can be the manufacturer of the qPCR test device, in which case the test result and / or status information of the qPCR test device are transmitted. Manual and thus error-prone processing of the test results is no longer necessary. Automated storage in a central database or register is also possible, allowing more test results to be processed in a shorter time. Furthermore, the possibility of manipulation of the test results is reduced, as there is no intermediate step involving employees.

[0065] Preferably, the test module is designed to detect COVID, influenza, and / or RSV (respiratory syncytial virus infections). Thus, the qPCR test device can be designed for the dedicated detection of one pathogen. Alternatively, the qPCR test device can be designed to detect different pathogens.

[0066] Preferably, the test module is designed to accommodate multiple test samples for testing. This allows the test module to simultaneously test multiple test samples for possible viral load. This further increases processing speed and makes test results available more quickly.

[0067] Preferably, one test result can be transmitted. Alternatively, a plurality of test results can be transmitted simultaneously. Likewise, the transmitted status information can contain a single status of the qPCR test device, which is then transmitted. Alternatively, the status information contains a plurality of different pieces of information about the status of the qPCR test device, which are preferably transmitted simultaneously.

[0068] Preferably, the transmission module is designed to establish a secure connection with the at least one receiver. For example, SSL is used between the qPCR test device and the receiver, whereby a secure connection can be established by means of certificate exchange. This further reduces the possibility of manipulation and increases data security.

[0069] Preferably, the transmission module is designed to transmit the test result to multiple recipients. Alternatively or additionally, the transmission module is designed to transmit status information to multiple recipients. Thus, it is possible for the qPCR test device to transmit the test result not only to one recipient, but also to enable the test result and / or status information to be made available to multiple recipients simultaneously. Particularly within the framework of a healthcare system that is interested in monitoring the spread of possible diseases, it may be necessary to transmit test results, particularly in anonymized form, to multiple recipients in order to, for example, provide statistics, forecasts, or information to citizens about the spread of the disease and / or the burden on the healthcare system.Manual transmission of test results within these information systems, which would lead to delays and errors, is no longer necessary.

[0070] The status information preferably comprises one or more of a connection state of the qPCR test device, an error indicator, and a test execution indicator. The connection state can be used to determine whether the qPCR test device is online and capable of transmitting test results via the transmission module. The error indicator can be used to display error states of the qPCR test device. In particular, if the status information is transmitted to the manufacturer of the qPCR test devices, the manufacturer can derive possible repairs from this and prepare them accordingly. At the same time, the error indicator ensures that only correct test results are forwarded. If the error indicator thus indicates an error that could, in particular, influence the test result, further tests by the qPCR test device are excluded or their test results are discarded.The test execution indicator indicates whether the qPCR test device is currently performing a test. This allows the activity of the qPCR test device to be further monitored. In particular, it can establish a causal connection between the performance of a test and the provision of test results, thus further complicating the provision of manipulated test results.

[0071] The test results preferably comprise one or more of a test indicator, a viral load, a personal ID, and a verification indicator. The test indicator provides an indication of the test subject's illness. The test indicator can, in particular, be binary and thus represent the result of the evaluation of the qPCR test. Furthermore, the test result can contain a viral load determined by the qPCR test. Furthermore, the test result can contain a personal ID. In particular, the personal ID is an anonymized identification of the test subject. This personal ID can, for example, be provided as a barcode, which is used to assign the samples. In particular, the personal ID does not contain any personal information (such as name, address, passport number, or the like) and is generated, for example, by the testing device.In particular, the personal ID contains a device ID of the qPCR test device. This ensures that the personal ID of the respective qPCR test device is unique and prevents collisions between personal IDs from different test devices. Alternatively, the personal ID is assigned centrally to ensure the uniqueness of the personal ID. Furthermore, the test result can include a verification indicator. The verification indicator indicates whether the sample is a human sample. This prevents tampering with the sample, particularly during sample collection.

[0072] Preferably, the status information is transmitted periodically to the at least one recipient, in particular via an HTTP request. This provides a simple transmission path for the status information to the at least one recipient. The status information can be transmitted to the at least one recipient, for example, once per hour, once per minute, or every 10 seconds. The present invention is not limited to a specific frequency of transmission of the status information, as long as this frequency is high enough to ensure reliable monitoring of the qPCR test device and its functionality.

[0073] Preferably, access information for a recipient is stored in the transmission module or the control module. Alternatively, the qPCR test device has a memory module, wherein the memory module is connected to the control module and / or the transmission module and is designed to store access data for a recipient. This access information can, for example, comprise a password and / or a device ID. The access information makes it possible to transmit test results and / or status information to the recipient. If the recipient is, for example, a public / official body for registering test results or a database, access to this public body or the database is protected. Test results and / or status information can only be transmitted to the central body or the recipient if the access information is available.If the access information does not match the access information stored by the recipient for the corresponding qPCR test device, transmission of the test results and / or status information to this recipient is not possible.

[0074] The transmission module is preferably designed to transmit the access information for a second recipient to a first recipient. In this way, access information, for example, can be transmitted automatically from the qPCR test device directly to the first recipient together with the test results and / or status information. The data is then transmitted on to the second recipient, with the access information being used to forward the test results to the second recipient or to store them there, as described above. The access information is transmitted from the qPCR test device to the first recipient in encrypted form, in particular as a JASON Web Token, so that the first recipient has no knowledge of the access information. Decryption by the first recipient is not possible. Only upon receipt of the access information orof the JASON Web Token by the second recipient, the latter can decrypt the encrypted access information and use it as access information for further processing / storing the test result. The transmitted test results and / or status information are thus received and further processed by the second recipient. This enables a flexible design of the information flow from the qPCR test device to the multiple recipients. For example, the test results and / or status information can initially be transmitted from the qPCR test device to the first recipient, in particular via a secure SSL connection. The first recipient could be, for example, the manufacturer of the qPCR test device or a service provider. The test results and / or status information are then forwarded from the second recipient to a second recipient.The second recipient could be, for example, a public / official body such as a health authority, a pharmacy association, a doctors' association, or the like, which is to further process the test results. The corresponding access data, which contains access to the second recipient for storing the test results, is transmitted by the qPCR test device, particularly in encrypted form, for example as a JASON Web Token. Knowledge of the access data by the manufacturer as the first recipient is thus precisely excluded, since decryption of the access information by the first recipient does not occur or is excluded. Nevertheless, forwarding to the second recipient can occur. If additional or other second recipients are also to be provided with the test results, it is no longer necessary to reconfigure individual qPCR test devices.Instead, the first recipient, such as the manufacturer or a service provider, can then forward the information directly and centrally to these new second recipients. This makes the flow of information flexible and makes it easy to adjust to whom the respective test results and / or status information is forwarded.

[0075] Furthermore, the present invention preferably relates to a system comprising a qPCR test device as described above and at least one first receiver.

[0076] Preferably, the first receiver is configured to forward test results to a second receiver.

[0077] Preferably, the first recipient is a manufacturer of the qPCR test device or a service provider. In particular, the second recipient is a public / official depository such as a health authority, a medical association, a pharmacist association, or the like.

[0078] Furthermore, the present invention relates to a method for transmitting test results of a point-of-care real-time quantitative PCR test device (qPCR test device) comprising the steps:

[0079] - Generation of a test result and / or status information and

[0080] - Transmission of the test result and / or status information to at least one recipient.

[0081] Preferably, the qPCR test device is designed as described above.

[0082] Preferably, the transmission is wired or wireless using known transmission methods, for example, via the Internet using LAN, WLAN, a GSM standard, or another wireless transmission technology such as Bluetooth, ZigBee, or the like. The transmission can take place via multiple nodes or access points. In particular, the present invention is not limited to the specific method of transmitting the test results and / or status information. Preferably, the transmission is encrypted or secured, particularly using SSL.

[0083] Preferably, the status information is transmitted periodically to the at least one recipient.

[0084] Preferably, the test result is transmitted to multiple recipients. Transmission can occur directly from the qPCR test device to multiple recipients. Alternatively, the test results can be forwarded by one of the recipients.

[0085] Preferably, the status information is transmitted to only one recipient.

[0086] Preferably, access information for accessing a recipient is stored on the qPCR test device. This allows the test results to be sent to the at least one recipient along with the access information. The access information is required to ensure that the test results and / or status information are stored with the at least one recipient.

[0087] The access information is preferably transmitted in encrypted form, in particular using a JASON Web Token, together with the test results and / or status information to a first recipient. In this case, the transmission can be carried out using SSL security, for example. The test results are then forwarded using the access information to a second recipient, whereby the access information is required to deposit the test results with the second recipient. The first recipient can be, for example, the manufacturer of the qPCR test device or a service provider, whereby the second recipient can be, for example, a public / official body such as a health authority, a pharmacy association and / or a doctors' association. Thus, the test results can only be deposited for further use by the second recipient if the access information is available.The access information is forwarded without the first recipient gaining knowledge of it. Decryption of the access information by the first recipient is not possible. This means that the first recipient cannot, for example, deposit manipulated test results, as they have no knowledge of the access information. Unintentional reading of test results by the first recipient is also impossible, as they have no access to the second recipient.

[0088] Preferably, the at least one receiver determines the consumption of test samples or additional test material from the status information and / or planning information transmitted by the qPCR test device and / or the operator of the qPCR test device to the at least one receiver. The planning information can, for example, be information regarding tests to be performed in the future. This can, for example, be forwarded automatically by the operator of the qPCR test device to the first receiver. In particular, the receiver is the manufacturer of the qPCR test device or a service provider. If the number of available test samples or the availability of additional test material falls below a predetermined limit, a signal is triggered.This signal can be an optical or acoustic signal that is emitted by the at least one receiver. Alternatively, the signal is a control signal that triggers the automated provision of additional test samples or additional test material to the operator of the qPCR test device. In particular, the status information and / or planning information can be used to determine the expected quantity of required test samples and / or test material, thus adjusting the number of test samples to be subsequently delivered or the volume of test material to be subsequently delivered.

[0089] In the following, embodiments of the present invention are explained in more detail with reference to the drawings.

[0090] They show schematically:

[0091] Fig. 1 shows a device for taking samples according to an embodiment of the present invention, Fig. 2 shows the taking of samples by means of an embodiment of the device according to the invention,

[0092] Fig. 3 shows an embodiment of the device according to the invention with a closed closure device,

[0093] Fig. 4 Device from Fig. 3 with separated end element,

[0094] Fig. 5a Device according to Fig. 4 in which the sample liquid to be analyzed is poured into a PCR tube,

[0095] Fig. 5b Device according to Fig. 9 in which the sample liquid to be analyzed is poured into a PCR tube,

[0096] Fig. 6 Device according to Fig. 7 in open state and with swab

[0097] Fig. 7 an embodiment of the device according to the invention with closed closure device

[0098] Fig. 8 Scanning of an identification code on one embodiment of a device according to the invention, and

[0099] Fig. 9 Device from Fig. 6 with separated end element

[0100] Fig. 1 shows an embodiment of the device according to the invention for receiving samples, in particular saliva samples or nasopharygeal swab samples, for carrying out a PCR analysis method for determining pathogenic microorganisms, in particular pathogenic viruses, especially viruses that cause respiratory diseases, in particular coronaviruses, especially SARS-CoV-2 viruses. The device comprises a receiving container 2 having a first opening 4.

[0101] Furthermore, a closure device 6 is provided, which is adapted to the opening 4 of the receiving container 2, so that the opening 4 of the receiving container 2 can be closed with the closure device 6. Furthermore, a sampling device 8 is shown, which has at least one first sampling element 12 at a first free end 10. The sample can be taken with the sampling element 12. The sampling element 12 can be made of a material that can be absorbent or adhesive with respect to liquids. This means that the sampling element can absorb the liquid, or the liquid can adhere to the sampling element.

[0102] An absorbent material can be, for example, a cotton element. The sampling element preferably comprises cotton threads or Dacron fibers. In special embodiments, the sampling element comprises microfibers. These improve absorption and increase the absorption volume of the sample material.

[0103] The sampling device 8 is connected to the closure device 6 at the second end 14 opposite the first free end 10. The sampling device 8 can be inserted into the receiving container 2 by means of the closure device 6.

[0104] The sampling device 8 has at least one hollow rod-shaped element 16. The sampling element 12 is arranged at the free end of the rod-shaped element 16. The hollow rod-shaped element 16 forms a channel 18 inside. The rod-shaped element 16 and thus the sampling device 8 are connected to the closure device 6 in this embodiment.

[0105] Preferably, the rod-shaped element 16 comprises a plastic, preferably comprising polyethylene and / or polypropylene.

[0106] The closure device 6 has a through-opening 20. The sampling element and thus the rod-shaped element 16 are connected to the closure device 6 such that the channel 18 opens into the through-opening 20 or is arranged therein. The rod-shaped element 18 can thus be arranged in the through-opening 20 and connected to the closure device 6 or connected to the closure device 6 at the end facing the sampling device 8, so that the channel 18 opens into the through-opening 20.

[0107] Figure 2 illustrates how a sample, particularly a saliva sample, can be taken. For this purpose, the sampling device 8 can be inserted through the nose or mouth, and the sample can be taken using the sampling element 12.

[0108] Fig. 3 shows how the receiving container 2 is closed with the closure device 6. The closure device closes the opening 4. With a closure device, the receiving container 2 can be sealed liquid-tight and preferably airtight. The length of the sampling device 8 is selected such that, when the closure device 6 is closed, the sampling device 8 does not strike the bottom of the receiving container 2. Preferably, however, the sampling device 8 is long enough for the liquid preparation composition for performing a PCR test on-site (point of care; PoC) to be in contact with the sampling element 12 or for the sampling element to be immersed in the liquid.

[0109] After a sample has been taken with the sampling element 12, the sampling device 8 can be inserted into the receiving container 2. The opening 4 can be closed by means of the closure device 6, and the entire device can be transported safely without contamination reaching the sample.

[0110] According to the invention, the liquid preparation composition for conducting a PCR test on-site (point of care; PoC) is arranged in the receiving container 2, so that after the sample has been taken, the sampling device 8 is inserted into the receiving container 2 and the sampling element 12 is immersed directly into the liquid. The opening 4 can be closed by means of the closure device 6.

[0111] Furthermore, Fig. 3 shows a closure element 22 that closes the through-opening 20 of the closure element 6 to the outside. The closure element 22 is detachably connected to the closure element 6. As long as the closure element 22 is connected to the closure element 6, no liquid can escape to the outside through the channel 18 and the through-opening 20.

[0112] Fig. 4 shows the device according to Fig. 3, but with the difference that the end element 22 has been separated from the closure element 6. Preferably, the end element 22 can be separated from the closure element 6 by bending.

[0113] The hollow rod-shaped element 16 can have at least one opening at the free end 10. The opening can form the opening of the channel arranged in the rod-shaped element. In the present case, this can be the opening 24 arranged in the withdrawal element 12. The liquid passing through the withdrawal element 12 can then be guided through the channel 18 to the through-opening 22 and, when the closure element 22 is detached, can exit the receiving container 2 there. The liquid can be guided to the through-opening 22 due to capillary action and / or pressure and / or negative pressure and, when the closure element 22 is detached, can exit the receiving container 2 there.

[0114] This is illustrated, for example, in Fig. 5a. There, the preparation composition for performing a PCR test on-site (point of care; PoC), which has been brought into contact with the biological sample, is poured from the receiving container 2 into a first PCR tube A1. This can then be used for further PCR testing directly on-site.

[0115] The opening in the rod-shaped element 16 can also be arranged in the surrounding wall and / or can also be arranged in the area adjacent to the closure device 6. At least one opening can also be arranged in this area and an additional opening can be arranged in the area of ​​the removal element 12.

[0116] Fig. 7 shows an embodiment of the device according to the invention for receiving samples, in particular saliva samples or nasopharygeal swab samples, for carrying out a PCR analysis method for determining pathogenic microorganisms, in particular pathogenic viruses, especially viruses that cause respiratory diseases, in particular coronaviruses, especially SARS-CoV-2 viruses. The device comprises a receiving container 2 having a first opening 4.

[0117] Furthermore, a closure device 6 is provided which is adapted to the opening 4 of the receiving container 2, so that the opening 4 of the receiving container 2 can be closed with the closure device 6.

[0118] The closure device 6 has a through-opening (not shown). Furthermore, a closure element 22 is shown, which closes the through-opening of the closure element 6 to the outside. The closure element 22 is detachably connected to the closure element 6. As long as the closure element 22 is connected to the closure element 6, no liquid can escape to the outside through the channel 18 and the through-opening 20. Furthermore, the receptacle can have an identification code 26.

[0119] Figure 6 shows the embodiment according to Fig. 7, in which the closure element 6 has been separated from the receiving container 2. After a sample has been taken with the sampling element 30, the sampling device 8 can be inserted into the receiving container 2. The taken sample is brought into contact with the liquid preparation composition located in the receiving container for on-site (point of care; PoC) PCR testing. The closure device 6 can be used to close the opening 4, allowing the entire device to be transported safely without contamination reaching the sample.

[0120] According to the invention, the liquid preparation composition for performing a PCR test on-site (point of care; PoC) is arranged in the receiving container 2, so that after the sample has been taken, the sampling device 8 is inserted into the receiving container 2 and the sampling element 30 is immersed directly into the liquid. The opening 4 can be closed by means of the closure device 6. The sampling element 8 comprises a rod-shaped element 28 and the sampling element 30. Fig. 8 shows the embodiment according to Fig. 7 with an identification code 26, which is scanned by a scanner 24.

[0121] Fig. 9 shows the device according to Fig. 7, but with the difference that the end element 22 has been separated from the closure element 6. Preferably, the end element 22 can be separated from the closure element 6 by bending.

[0122] Fig. 9 also shows a closure element 22 that has been separated and previously closes the through-opening 20 of the closure element 6 to the outside. The closure element 22 is detachably connected to the closure element 6. As long as the closure element 22 is connected to the closure element 6, no liquid can escape through the through-opening 20 to the outside.

[0123] The liquid preparation composition for on-site (point-of-care; PoC) PCR testing, which has been brought into contact with the biological sample, can be poured from the receiving container 2 into a first PCR tube A1 (Fig. 5b). This can then be used for further PCR testing directly on-site.

[0124] Example: PoC PCR for SARS CoV-2 viruses

[0125] The device according to the invention for collecting biological samples shown in Figures 7 and 9 contains an aqueous preparation composition for on-site PCR testing comprising guanidinium thiocyanate, surfactant, two different RNAse inhibitors, a SARS-CoV-2 virus neutralizing antibody, and biotin.

[0126] Nasospharygeal secretion is taken from a patient using a swab and brought into contact with the treatment composition in the device according to the invention. The treatment composition combined with the secretion is then incubated for 5 minutes at 20°C. One drop (30 μl) is filled through the opening in the closure into a PCR sample tube containing a PCR reaction mixture comprising polymerase, primers, and probes for the detection of SARS-CoV-2 viruses. The PCR sample tube is then placed directly into a PoC-PCR test device (thermocycler). The result is available after 10 to 30 minutes.

Claims

Claims 1. Device (1) for receiving biological samples for carrying out a PCR analysis procedure for the determination of pathogenic microorganisms, in particular pathogenic viruses, especially viruses that cause respiratory diseases, comprising a receiving container (2) with a first opening (4), a closure device (6) adapted to the opening (4) of the receiving container (2) so that the opening (4) of the receiving container (2) can be closed with the closure device (6), wherein the closure device (6) has a through-opening (20), characterized in that the receiving container (2) contains a liquid preparation composition for on-site (point of care; PoC) performance of a PCR test.

2. Device according to claim 1, characterized in that the device further comprises a sampling device (8) which has at least a first sampling element (12) at a first free end (10) with which the sample can be taken, and wherein the sampling device (8) can be inserted into the receiving container (2).

3. Device according to claim 2, characterized in that the sampling device (8) is connected to the closure device (6) at a second end (14) opposite the first free end (10), so that the sampling device (8) can be inserted into the receiving container (2) by means of the closure device (6).

4. Device according to one of claims 1 to 3, characterized in that the through-opening (20) of the closure device (6) is closed by means of a closing element (22), wherein the closing element (22) is separably attached to the closure element.

5. Device according to one of claims 2 to 4, characterized in that the sampling device (8) comprises at least one hollow rod-shaped The device comprises an element (16) at the free end of which the sampling element (12) is arranged, wherein the hollow rod-shaped element (16) forms a channel (18) inside. A device according to any one of claims 2 to 5, characterized in that the rod-shaped element (16) is connected to the closure device (6) such that the channel (18) of the rod-shaped element (16) opens into or is arranged in the through-opening (20). A device according to claim 6, characterized in that the through-opening of the closure element is closed on the side opposite the sampling element by means of a closing element which is separably attached to the closure element. A device according to any one of claims 4 to 7, characterized in that the closing element can be separated from the closure element by bending.Device according to any one of claims 2 to 8, characterized in that the hollow rod-shaped element has at least one opening at its free end. Device according to claim 9, characterized in that the end of the channel arranged in the rod-shaped element forms the opening at the free end. Device according to claim 9 or 10, characterized in that the opening arranged at the free end is located in the wall of the rod-shaped element. Device according to any one of claims 1 to 11, characterized in that the device, in particular the receiving container, has an identification code. A device according to any one of claims 1 to 12, characterized in that the viruses are coronaviruses, in particular SARS-CoV-2 viruses. A device according to any one of claims 1 to 12, characterized in that one or more viruses are selected from the group consisting of SARS-CoV-2 virus, influenza virus, and adenovirus. A device according to any one of claims 1 to 14, characterized in that the PCR test is a quantitative PCR method (qPCR) or a quantitative real-time PCR (RT-qPCR). A device according to any one of claims 1 to 15, characterized in that the biological sample is saliva and / or nasopharyngeal secretion. A device according to any one of claims 1 to 16, characterized in that the liquid preparation composition contains guanidinium thiocyanate.Device according to one or more of claims 1 to 17, characterized in that the liquid preparation composition contains one or more surfactants. Device according to one or more of claims 1 to 18, characterized in that the liquid preparation composition contains one or more RNAase inhibitors, preferably two different RNAase inhibitors. Device according to one or more of claims 1 to 19, characterized in that the liquid preparation composition contains a buffer. Device according to one or more of claims 1 to 20, characterized in that the liquid preparation composition contains biotin. Use of the apparatus according to any one of claims 1 to 21 for a point-of-care PCR (PoC) test procedure. A method for performing a point-of-care PCR (PoC-PCR) procedure comprising the following steps: a) providing an apparatus according to any one of claims 1 to 21, b) contacting a biological sample, preferably saliva and / or nasopharyngeal secretions, with the liquid preparation composition for performing a point-of-care (PoC) PCR test, c) using the liquid preparation composition comprising the biological sample in a PoC-PCR procedure. A method according to claim 23, characterized in that the liquid preparation composition is incubated together with the sample, preferably at 15 to 30 °C and particularly for a period of 1 to 30 minutes, specifically 2 to 15 minutes and particularly 3 to 10 minutes.A method according to claim 23 or 24, characterized in that the sample preparation composition is mixed with a PCR reaction mixture. A method according to one or more of claims 23 to 25, characterized in that the PCR reaction mixture comprises polymerase and primers and probes for the detection of pathogenic microorganisms, in particular pathogenic viruses, especially viruses that cause respiratory diseases. A method according to one or more of claims 23 to 26 comprising the following steps: a) providing a device according to one of claims 1 to 21, b) bringing a biological sample, preferably saliva and / or nasopharyngeal secretions, into contact with the liquid preparation composition. a) for performing a PCR test on-site (point of care; PoC) for the detection of coronaviruses, in particular SARS-CoV-2 viruses, c) optionally incubating the liquid preparation composition together with the biological sample, d) mixing the liquid preparation composition comprising the biological sample with a PCR reaction mixture comprising polymerase and primers and probes for the detection of coronaviruses, in particular SARS-CoV-2 viruses. Method according to any one of claims 23 to 27, characterized in that the PoC-PCR method is a multiplex PCR method. Method according to any one of claims 23 to 28, characterized in that the PCR reaction mixture comprises two or more probes for the detection of SARS-CoV-2 viruses, two or more primers and polymerase, in particular Taq polymerase, reverse transcriptase and optionally a buffer.Kit comprising a) a device according to any one of claims 1 to 22, b) optionally a sample collection device and c) optionally a separate container with a PCR reaction mixture.